Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6917-22. Epub 2001 May 29.

2.

Prefrontal neurons and the genetics of schizophrenia.

Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE.

Biol Psychiatry. 2001 Dec 1;50(11):825-44. Review.

PMID:
11743939
3.
4.

Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics.

Diaz-Asper CM, Weinberger DR, Goldberg TE.

NeuroRx. 2006 Jan;3(1):97-105. Review.

5.
6.

Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.

Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, St Clair D, He L.

Biol Psychiatry. 2005 Jan 15;57(2):139-44. Review.

PMID:
15652872
7.

Schizophrenia, the prefrontal cortex, and a mechanism of genetic susceptibility.

Weinberger DR.

Eur Psychiatry. 2002 Aug;17 Suppl 4:355s-362s. Review.

PMID:
23573605
8.

Catechol-O-methyl transferase and schizophrenia.

Sagud M, Mück-Seler D, Mihaljević-Peles A, Vuksan-Cusa B, Zivković M, Jakovljević M, Pivac N.

Psychiatr Danub. 2010 Jun;22(2):270-4. Review.

9.

Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.

Dauvilliers Y, Tafti M, Landolt HP.

Sleep Med Rev. 2015 Aug;22:47-53. doi: 10.1016/j.smrv.2014.10.006. Epub 2014 Oct 27. Review.

PMID:
25466290
10.

Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia.

Gupta M, Kaur H, Jajodia A, Jain S, Satyamoorthy K, Mukerji M, Thirthalli J; Indian Genome Variation Consortium, Kukreti R.

Curr Mol Med. 2011 Dec;11(9):732-43. Review.

PMID:
21999147
11.

COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation.

Ira E, Zanoni M, Ruggeri M, Dazzan P, Tosato S.

J Psychiatry Neurosci. 2013 Nov;38(6):366-80. doi: 10.1503/jpn.120178. Review.

12.

Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.

Tunbridge EM, Harrison PJ, Weinberger DR.

Biol Psychiatry. 2006 Jul 15;60(2):141-51. Epub 2006 Feb 14. Review.

PMID:
16476412
13.

Neurobiology of aggression and violence in schizophrenia.

Soyka M.

Schizophr Bull. 2011 Sep;37(5):913-20. doi: 10.1093/schbul/sbr103. Review.

14.
15.

Genes, cognition and brain through a COMT lens.

Dickinson D, Elvevåg B.

Neuroscience. 2009 Nov 24;164(1):72-87. doi: 10.1016/j.neuroscience.2009.05.014. Epub 2009 May 13. Review.

16.

Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia.

Tan HY, Callicott JH, Weinberger DR.

Cereb Cortex. 2007 Sep;17 Suppl 1:i171-81. Review.

PMID:
17726000
17.

The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons.

Craddock N, Owen MJ, O'Donovan MC.

Mol Psychiatry. 2006 May;11(5):446-58. Review.

PMID:
16505837
18.
19.

The role of catechol-O-methyltransferase in reward processing and addiction.

Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton ME.

CNS Neurol Disord Drug Targets. 2012 May;11(3):306-23. Review.

PMID:
22483300
20.

Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential.

Lawrie SM, Hall J, McIntosh AM, Cunningham-Owens DG, Johnstone EC.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S120-4. doi: 10.1038/sj.bjp.0707655. Epub 2008 Jan 14. Review.

Supplemental Content

Support Center